The First Affiliated Hospital of Chongqing Medical University
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-08-18 | NCT06656494 | |
| A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer | IO-resistant sqNSCLC | Recruiting | Phase 3 | 2026-08-04 | NCT07217301 | |
| Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, intestinal disorder, lung cancer, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm, thyroid gland disorder, thyroid tumor, uterine disorder, vulva cancer, vulvar disease | Recruiting | Phase 1 / Phase 2 | 2026-02-25 | NCT07433283 | |
| Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis | Active, not recruiting | Phase 4 | 2026-02-12 | NCT06332014 | |
| A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 3 | 2026-01-30 | NCT04854668 | |
| A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer | Advanced Renal Cancer | Active, not recruiting | Phase 3 | 2024-10-15 | NCT04523272 | |
| Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System | cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Not yet recruiting | Not applicable | 2021-08-06 | NCT04995159 |